BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 16896662)

  • 1. Can the detection of misery perfusion in chronic cerebrovascular disease be based on reductions in baseline CBF and vasoreactivity?
    Okazawa H; Tsuchida T; Kobayashi M; Arai Y; Pagani M; Isozaki M; Yonekura Y
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):121-9. PubMed ID: 16896662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of cerebrovascular reserve in acetazolamide challenge -comparison with acetazolamide challenge H2O-PET and Gas-PET.
    Imaizumi M; Kitagawa K; Oku N; Hashikawa K; Takasawa M; Yoshikawa T; Osaki Y; Matsushita K; Matsumoto M; Hori M; Hatazawa J
    Ann Nucl Med; 2004 Jul; 18(5):369-74. PubMed ID: 15462398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of central benzodiazepine receptor binding potential/cerebral blood flow SPECT imaging for detecting misery perfusion in patients with unilateral major cerebral artery occlusive diseases: comparison with cerebrovascular reactivity to acetazolamide and cerebral blood flow SPECT imaging.
    Kuroda H; Ogasawara K; Suzuki T; Chida K; Aso K; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Kubo Y; Ogawa A
    Clin Nucl Med; 2012 Mar; 37(3):235-40. PubMed ID: 22310248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implication and prognosis of normal baseline cerebral blood flow with impaired vascular reserve in patients with major cerebral artery occlusive disease.
    Isozaki M; Arai Y; Kudo T; Kiyono Y; Kobayashi M; Kubota T; Kikuta K; Okazawa H
    Ann Nucl Med; 2010 Jun; 24(5):371-7. PubMed ID: 20238185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease.
    Okazawa H; Yamauchi H; Sugimoto K; Takahashi M
    J Nucl Med; 2003 Sep; 44(9):1371-8. PubMed ID: 12960179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral oxygen metabolism and neuronal integrity in patients with impaired vasoreactivity attributable to occlusive carotid artery disease.
    Kuroda S; Shiga T; Houkin K; Ishikawa T; Katoh C; Tamaki N; Iwasaki Y
    Stroke; 2006 Feb; 37(2):393-8. PubMed ID: 16385090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
    Okazawa H; Yamauchi H; Toyoda H; Sugimoto K; Fujibayashi Y; Yonekura Y
    J Nucl Med; 2003 Dec; 44(12):1875-83. PubMed ID: 14660711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases.
    Kuroda S; Shiga T; Ishikawa T; Houkin K; Narita T; Katoh C; Tamaki N; Iwasaki Y
    J Nucl Med; 2004 Jun; 45(6):943-9. PubMed ID: 15181128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative central benzodiazepine receptor binding potential and cerebral blood flow images on SPECT predict development of new cerebral ischemic events and cerebral hyperperfusion after carotid endarterectomy.
    Sato Y; Ogasawara K; Kuroda H; Suzuki T; Chida K; Fujiwara S; Aso K; Kobayashi M; Yoshida K; Terasaki K; Ogawa A
    J Nucl Med; 2011 Sep; 52(9):1400-7. PubMed ID: 21795362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of 62Cu-ATSM PET for evaluation of brain ischaemia and misery perfusion in patients with cerebrovascular disease.
    Isozaki M; Kiyono Y; Arai Y; Kudo T; Mori T; Maruyama R; Kikuta K; Okazawa H
    Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1075-82. PubMed ID: 21287169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of brain perfusion single-photon emission computed tomography for detecting misery perfusion in adult patients with symptomatic ischemic moyamoya disease.
    Setta K; Kojima D; Shimada Y; Yoshida J; Oshida S; Fujimoto K; Tsutsui S; Chiba T; Fujiwara S; Terasaki K; Ogasawara K
    Ann Nucl Med; 2018 Nov; 32(9):611-619. PubMed ID: 30030783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetazolamide-augmented dynamic BOLD (aczBOLD) imaging for assessing cerebrovascular reactivity in chronic steno-occlusive disease of the anterior circulation: An initial experience.
    Wu J; Dehkharghani S; Nahab F; Qiu D
    Neuroimage Clin; 2017; 13():116-122. PubMed ID: 27942454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET evaluation of cerebral hemodynamics in occlusive cerebrovascular disease pre- and postsurgery.
    Kuwabara Y; Ichiya Y; Sasaki M; Yoshida T; Fukumura T; Masuda K; Fujii K; Fukui M
    J Nucl Med; 1998 May; 39(5):760-5. PubMed ID: 9591570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of misery perfusion with split-dose 123I-iodoamphetamine single-photon emission computed tomography in patients with carotid occlusive diseases.
    Imaizumi M; Kitagawa K; Hashikawa K; Oku N; Teratani T; Takasawa M; Yoshikawa T; Rishu P; Ohtsuki T; Hori M; Matsumoto M; Nishimura T
    Stroke; 2002 Sep; 33(9):2217-23. PubMed ID: 12215590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral blood flow and oxygen metabolism measurements using positron emission tomography on the first day after carotid artery stenting.
    Kawai N; Hatakeyama T; Okauchi M; Kawanishi M; Shindo A; Kudomi N; Yamamoto Y; Nishiyama Y; Tamiya T
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e55-64. PubMed ID: 24119366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting misery perfusion in unilateral steno-occlusive disease of the internal carotid artery or middle cerebral artery by MR imaging.
    Xie S; Hui LH; Xiao JX; Zhang XD; Peng Q
    AJNR Am J Neuroradiol; 2011 Sep; 32(8):1504-9. PubMed ID: 21700788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral MR oximetry during acetazolamide augmentation: Beyond cerebrovascular reactivity in hemodynamic failure.
    Leatherday C; Dehkharghani S; Nahab F; Allen JW; Wu J; Hu R; Qiu D
    J Magn Reson Imaging; 2019 Jul; 50(1):175-182. PubMed ID: 30390367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constant-infusion H(2)15O PET and acetazolamide challenge in the assessment of cerebral perfusion status.
    Weber B; Westera G; Treyer V; Burger C; Khan N; Buck A
    J Nucl Med; 2004 Aug; 45(8):1344-50. PubMed ID: 15299060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusive disease: a SPECT study.
    Saura H; Ogasawara K; Suzuki T; Kuroda H; Yamashita T; Kobayashi M; Terasaki K; Ogawa A
    Cerebrovasc Dis; 2012; 33(4):354-61. PubMed ID: 22433127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic CT perfusion imaging with acetazolamide challenge for evaluation of patients with unilateral cerebrovascular steno-occlusive disease.
    Chen A; Shyr MH; Chen TY; Lai HY; Lin CC; Yen PS
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1876-81. PubMed ID: 17032859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.